ALLARITY THERAPEUTICS, INC. — Key Metrics
1 years of history · ending 2020-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
Per Share Metrics
Working Capital Analysis
ROIC vs WACC
EPS (Diluted)
$-2
Book Value Per Share
$7
Free Cash Flow Per Share
$-2
Cash Per Share
$0
Revenue Per Share
—
OCF Per Share
$-2
Return on Equity
-27.1%
Return on Assets
-19.8%
Return on Invested Capital
-26.9%
Debt to Equity
—
Current Ratio
0.31
Quick Ratio
0.31
Asset Turnover
—
R&D / Revenue
—
SBC / Revenue
—
Capex / Revenue
—
Working Capital
$-4M
Net Current Asset Value
$-7M
Invested Capital
$24M
OCF / Net Income
1.10
FCF / Net Income
1.10
Accruals Ratio (Sloan)
1.9%
Net Debt
$-298K
Net Debt / EBITDA
0.04
Interest Coverage
-89.45
Cash Coverage
-77.97
Capex Coverage
-2417.00
Tangible Common Equity
$-6M
TCE / Total Assets
-18.1%
NOPAT
$-7M
Cash ROIC
-29.7%
WC / Revenue
—
Capex / D&A
0.07
Reinvestment Rate
0.5%
Total Payout Ratio
—
Book Value 5Y CAGR
—
Stock Price (FY-end)
—
Market Cap
—
P/S Ratio
—
P/B Ratio
—
Enterprise Value
—
EV / Sales
—
FCF Yield
—
Shareholder Yield
—
R&D Yield
—
Capex Yield
—
Shares Variation (YoY)
—
Beta (5Y)
—
Cost of Equity
—
Cost of Debt (after tax)
—
52W High
—
52W Low
—
Trailing Return 1Y
—
F-Score (Piotroski)
—
Z-Score (Altman)
—
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.